Share
14 February 2023
Linesight is delighted to share the recording of its recent public webinar, where a panel of experts provided an overview of the Linesight Capital Project Benchmarking programme and high-level insights that have emerged from analysis of over 168 global projects valued at US$26 billion. The programme commenced in 2020 and has grown into a global collaboration of 17 leading pharmaceutical companies benchmarking and aligning cost and schedule data across capital projects.
You can view the full recording below:
Linesight Life Sciences Benchmarking Webinar
Share
Related Insights
